<!-- ------------------ HEADER ------------------ -->
<!-- Developed and maintained by Jos&eacute; Miguel Lorenzo Salazar
<!-- Researcher on Human Genetics working at the Genomics Division
<!-- of the Institute of Technology an Renewable Energy (ITER)
<!-- Tenerife, Canary Islands, SPAIN
<!-- See the "Contact us" section to collaborate with us to growth
<!-- this repository. ;=)

<!-- ------------------ SECTION ------------------ -->
<p align="left">
  <a href="https://www.iter.es" title="Instituto Tecnológico y de Energ&iacute;as Renovables (ITER) / Institute of Technology and Renewable Energy (ITER)">
    <img src="https://www.iter.es/wp-content/uploads/2016/05/logo.png" width="30%" />
  </a>
</p>

# COVID-19
A public repository of scientific and media resources of SARS-CoV-2 related COVID-19 maintained by ITER.

<hr>
<!-- ------------------ SECTION ------------------ -->

> April 17, 2020 updates: 67 new selected preprints and published papers in the Viral mechanisms section courtesy of Prof. A. Valenzuela (ULL).

> As the repository increases its size, we are moving into a Wiki format (soon here!).

> Use the "Home" button to move up between sections and the ToC.

# Table of contents #
<ul>
  <li><a href="#Clinical Trials and Pharmacological Treatments">Clinical Trials and Pharmacological Treatments</a></li>
  <li><a href="#Educational resources">Educational resources</a></li>
  <li><a href="#Genomics of SARS-CoV-2">Genomics of SARS-CoV-2</a></li>
  <li><a href="#Guidelines, Society's Clinical and Professional Statements">Guidelines, Society's Clinical and Professional Statements</a></li>
  <li><a href="#Media sources">Media sources</a></li>
  <li><a href="#Protocols">Protocols</a></li>
  <li><a href="#Rapid Tests">Rapid Tests</a></li>
  <li><a href="#Research Coalitions and Funding Calls">Research Coalitions and Funding Calls</a></li>
  <li><a href="#Respirators, masks, and other Personal Protective Equipments (PPE)">Respirators, masks, and other Personal Protective Equipments (PPE)</a></li>
  <li><a href="#Scientific Communications and Literature (Pre-prints & Peer-Reviewed Papers)" >Scientific Communications and Literature (Pre-prints & Peer-Reviewed Papers)</a></li>
  <ul>
    <li><a href="#Maths and Epidemiological Models">Maths and Epidemiological Models </a></li>
    <li><a href="#PCR related articles">PCR related articles</a></li>
  </ul>
  <li><a href="#Sciencific Data and Resources" >Sciencific Data and Resources</a></li>
  <ul><li><a href="#Autonomous Regions and Cities in Spain" >Autonomous Regions and Cities in Spain</a></li></ul>
  <li><a href="#Sequencing, Sequences and Bioinformatics">Sequencing, Sequences and Bioinformatics</a></li>
  <li><a href="#Shiny and R related dashboards and packages">Shiny and R related dashboards and packages. Under construction</a></li>  
  <li><a href="#Viral mechanisms and Tropism">Viral mechanisms: infection, entry, and replication. Under construction</a></li>
  <li><a href="#Acknowledgements">Acknowledgements</a></li>
  <li><a href="#Contact us">Contact us</a></li>
  <li><a href="https://github.com/genomicsITER/COVID-19/blob/master/CONTRIBUTING.md">Contributing to this repository</a></li>
  <li><a href="https://github.com/genomicsITER/COVID-19/blob/master/CODE_OF_CONDUCT.md">Code of Conduct</a></li>
  <li><a href="#Update logs">Update logs</a></li>
  </ul>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Clinical Trials and Pharmacological Treatments"></a>
## Clinical Trials and Pharmacological Treatments ##
> Section to show on-going clinical trials to figth against COVID-19

[U.S. National Library of Medicine, ClinicalTrials.gov, Clinical Trials ordered by treatment](https://clinicaltrials.gov/ct2/results?cond=COVID&term=&cntry=&state=&city=&dist=)

<ul>

<li><a href="https://clinicaltrials.gov/ct2/results?term=anakinra&cond=COVID">Anakinra clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=azithromycin&cond=COVID">Azithromycin clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=baricitinib&cond=COVID">Baricitinib clinical trials</a></li>
 
<li><a href="https://clinicaltrials.gov/ct2/results?term=cobicistat&cond=COVID">Cobicistat clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=colchicina&cond=COVID">Colchicina clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=darunavir&cond=COVID">Darunavir clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=hydrychloroquine&cond=COVID">Hydrychloroquine clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=interferon&cond=COVID">Interferon clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=lopinavir&cond=COVID">Lopinavir clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=remdesivir&cond=COVID">Remdesivir clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=ritonavir&cond=COVID">Ritonavir clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=sarilumab&cond=COVID">Sarilumab clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=siltuximab&cond=COVID">Siltuximab clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=tocilizumab&cond=COVID">Tocilizumab clinical trials</a></li>

</ul>

[Clinical Trials in Spain](https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=&cntry=ES&state=&city=&dist=&Search=Search)

[European Union Clinical Trials Register, Clinical trials for COVID-19](https://www.clinicaltrialsregister.eu/ctr-search/search?query=covid-19)

[WHO DRAFT landscape of COVID-19 candidate vaccines, now includes two Spanish pre-clinical trials (April 11)](https://www.who.int/blueprint/priority-diseases/key-action/Novel_Coronavirus_Landscape_nCoV_11April2020.PDF)

[Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). A review](Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). A Review)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Educational resources"></a>
## Educational resources ##
[Harvard Medical School MEDICAL STUDENT COVID-19 CURRICULUM](https://docs.google.com/document/d/13JfRRw1GEIKz4JCde8WcQBCHnu-7nn11P_z0dHov1eA/preview#)

[#AprendeBioinformáticaEnCasa](https://bioinfogp.cnb.csic.es/courses/quedateencasa/)

[Bioinformatics Training Resources for Experimentalists (and Friends)](https://jasondk.github.io/bioinformatics-edu/)

[Czech campaign #masks4all](https://docs.google.com/document/u/0/d/1EWpWmyjzM4sNBF-7jp_1Y9a-pqiRg0wakGXy7kj11RA/mobilebasic)
[We need #masks4all, in Youtube](https://youtu.be/BoDwXwZXsDI)

[IAEA International Atomic Energy Agency webinar, COVID-19 and chest CT: protocol and dose optimization](https://www.iaea.org/resources/webinar/covid-19-and-chest-ct-protocol-and-dose-optimization)
<p align="center">
    <a href="https://www.iaea.org/resources/webinar/covid-19-and-chest-ct-protocol-and-dose-optimization" title="See this resource">
      <img src="https://www.iaea.org/sites/default/files/iaea-logo.png" width="40%"/>
    </a> 
</p>

[COVID-19 Preparedness for Radiotherapy Departments - Towards Consensus on Best Practices](https://humanhealth.iaea.org/HHW/)
<p align="center">
    <a href="https://humanhealth.iaea.org/HHW/" title="See this resource">
      <img src="https://humanhealth.iaea.org/HHW/resources/images/product-name.png" width="40%"/>
    </a> 
</p>

[Actualización sobre la situación de la COVID-19, Dr. Josep Maria Miró](https://www.youtube.com/watch?v=VcURN4NnaJI)

[SARS-CoV-2 (COVID-19) by the n. EPIDEMIOLOGY AND GLOBAL HEALTH MICROBIOLOGY AND INFECTIOUS DISEASE elife](https://elifesciences.org/articles/57309)

[International AIDS Society COVID-19 and HIV: Webinar series: "COVID-19 and HIV: What you need to know"](https://www.iasociety.org/HIV-Programmes/Cross-cutting-issues/COVID-19-and-HIV-Webinars)

[Infectious Disease Modelling: Beyond the Basic SIR Model](https://towardsdatascience.com/infectious-disease-modelling-beyond-the-basic-sir-model-216369c584c4)

[COVID19: Top 7 online interactive simulations, curated](https://towardsdatascience.com/covid19-top-7-online-interactive-simulations-curated-fa4282889875)

[Los virus más infecciosos del último siglo, en imágenes, diario El País, España](https://elpais.com/elpais/2020/04/14/album/1586870301_739813.html)

[The woman who discovered the first coronavirus](https://www.bbc.com/news/uk-scotland-52278716)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Genomics of SARS-CoV-2"></a>
## Genomics of SARS-CoV-2 ##
> Section devoted to show main findings in the virus genome.

[Reproducible analyses for rejecting rare genomic inversions in SARS-CoV-2](https://github.com/alexcritschristoph/sars_cov_2_inversion)

[SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies](https://www.biorxiv.org/content/10.1101/2020.03.27.009480v1)

[Proyecto Epidemiologia Genomica COVID 19](https://evosalut1.uv.es/)

[CovProfile: profiling the viral genome and gene expressions of SARS-COV2](https://www.biorxiv.org/content/10.1101/2020.04.05.026146v1)

[MERS-CoV recombination: implications about the reservoir and potential for adaptation](https://academic.oup.com/ve/article/2/1/vev023/1753363)

[Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa203/5780800)

[The proximal origin of SARS-CoV-2](https://www.nature.com/articles/s41591-020-0820-9)

[Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal](https://mra.asm.org/content/9/11/e00169-20)

[Nanopore target sequencing for accurate and comprehensive detection of SARS-CoV-2 and other respiratory viruses](https://www.medrxiv.org/content/10.1101/2020.03.04.20029538v1)

[Genomic variations of SARS-CoV-2 suggest multiple outbreak sources of transmission](https://www.medrxiv.org/content/10.1101/2020.02.25.20027953v2)

[A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing](https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3)

[SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues](https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3555145)

[RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak](https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1725399)

[Global patterns in coronavirus diversity](https://academic.oup.com/ve/article/3/1/vex012/3866407)

[Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic](https://www.biorxiv.org/content/10.1101/2020.03.30.015008v1)

[LAMP-Seq: Population-Scale COVID-19 Diagnostics Using a Compressed Barcode Space](https://www.biorxiv.org/content/10.1101/2020.04.06.025635v1)

[Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site](https://www.biorxiv.org/content/10.1101/2020.03.22.002204v1)

[The architecture of SARS-CoV-2 transcriptome](https://www.biorxiv.org/content/10.1101/2020.03.12.988865v2)

[Direct RNA sequencing and early evolution of SARS-CoV-2](https://www.biorxiv.org/content/10.1101/2020.03.05.976167v2)

[Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses](https://www.biorxiv.org/content/10.1101/2020.04.05.026450v1)

[Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue](https://www.biorxiv.org/content/10.1101/2020.04.07.030742v1)

[The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) envelope (E) protein harbors a conserved BH3-like motif](https://www.biorxiv.org/content/10.1101/2020.04.09.033522v1)

[Knowledge synthesis from 100 million biomedical documents augments the deep expression profiling of coronavirus receptors](https://www.biorxiv.org/content/10.1101/2020.03.24.005702v1.full.pdf)

[In-depth Bioinformatic Analyses of Human SARS-CoV-2, SARS-CoV, MERS-CoV, and Other Nidovirales Suggest Important Roles of Noncanonical Nucleic Acid Structures in Their Lifecycles](https://www.biorxiv.org/content/10.1101/2020.04.09.031252v1)

[Comparative ACE2 variation and primate COVID-19 risk](https://www.biorxiv.org/content/10.1101/2020.04.09.034967v1)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>
<!-- ------------------ END of GENOMICS SECTION ------------------ -->

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Guidelines, Society's Clinical and Professional Statements"></a>
## Guidelines
> A colection of guides and documents from different natianal and international institutions with means to protect people againts COVID-19, including biosafety guidelines, decontamination recommendations and risks, etc. 
> The opinions expressed in there do not reflect ITER institutional position.

[WHO - Laboratory Biosafety Manual - Third Edition](https://www.who.int/csr/resources/publications/biosafety/WHO_CDS_CSR_LYO_2004_11/en/) 

[SemiSyuc]() 
https://semicyuc.org/covid-19/#Documentos
[Plan de Contingencia para los Servicios de Medicina Intensiva frente a la pandemia COVID-19](https://semicyuc.org/wp-content/uploads/2020/03/Plan-Contingencia-COVID-19.pdf) 

[Recommended Guidance for Extended Use and Limited Reuse of N95 Filtering Facepiece Respirators in Healthcare Settings](https://www.cdc.gov/niosh/topics/hcwcontrols/recommendedguidanceextuse.html)

[Recomendaciones Institucionales de la Sociedad Española de Enfermedades Infeccionas y Microbiología Clínica (SEIMC)](https://seimc.org/documentos-cientificos/recomendaciones-institucionales) 

[Documento de posicionamiento de la SEIMC sobre el diagnstico microbiológo de COVID-19](https://seimc.org/contenidos/documentoscientificos/recomendaciones/seimc-rc-2020-Posicionamiento_SEIMC_diagnostico_microbiologico_COVID19.pdf)

[USA CDC Clean & Disinfect
Interim Recommendations for US Households with Suspected/Confirmed Coronavirus Disease 2019](https://www.cdc.gov/coronavirus/2019-ncov/prepare/cleaning-disinfection.html) 

[WHO Laboratory biosafety guidance related to coronavirus disease (COVID-19) interim guidance, 19 March 2020:](https://apps.who.int/iris/handle/10665/331500)
<p align="center">
    <a href="https://apps.who.int/iris/handle/10665/331500" title="See this resource">
      <img src="https://apps.who.int/iris/themes/WHO//images/en/who_logo.svg" width="30%"/>
    </a> 
</p>

[Novel Coronavirus (COVID-19): The American Thoracic Society (ATS) Response](https://www.thoracic.org/professionals/clinical-resources/disease-related-resources/novel-coronavirus.php)
<p align="center">
    <a href="https://www.thoracic.org/professionals/clinical-resources/disease-related-resources/novel-coronavirus.php" title="See this resource">
      <img src="https://www.thoracic.org/_files/images/logoats.jpg" width="40%"/>
    </a> 
</p>

[CEN and CENELEC make European standards available to help prevent the COVID-19 contagion](https://www.cencenelec.eu/News/Press_Releases/Pages/PR-2020-003.aspx)
<p align="center">
    <a href="https://www.cencenelec.eu/News/Press_Releases/Pages/PR-2020-003.aspx" title="See this resource">
      <img src="https://www.cencenelec.eu/_layouts/1033/STYLES/CENCENELECResponsive/img/device-cen-cenelec.gif" width="40%"/>
    </a> 
</p>

[European CDC, Considerations relating to social distancing measures in response to COVID-19 – second update](https://www.ecdc.europa.eu/en/publications-data/considerations-relating-social-distancing-measures-response-covid-19-second)
<p align="center">
    <a href="https://www.ecdc.europa.eu/en/publications-data/considerations-relating-social-distancing-measures-response-covid-19-second" title="See this resource">
      <img src="https://www.ecdc.europa.eu/profiles/custom/ecdc/themes/anthrax/images/logo-ecdc.png" width="25%"/>
    </a> 
</p>

[WHO Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts](https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts)

[WHO several guidelines to protect Workers Health](https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/health-workers)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Media sources"></a>
## Media sources
> Selected media articles because of their informative content.
> The opinions expressed in there do not reflect ITER institutional position.

[Financial Times](https://www.ft.com/coronavirus-latest) 

[Example of a device using UV-C for decontamination](https://www.tmghealthtech.com/rds-32) 

[Example of a Rapid Bio Decontamination Service, from Bioquell](https://www.bioquell.com/life-sciences/systems-and-services/decontamination/?lang=en-uk) 

[How did Spain get its coronavirus response so wrong?](https://www.theguardian.com/world/2020/mar/26/spain-coronavirus-response-analysis)

[Mount Sinai to Begin the Transfer of COVID-19 Antibodies into Critically Ill Patients](https://inside.mountsinai.org/blog/mount-sinai-to-begin-the-transfer-of-covid-19-antibodies-into-critically-ill-patients/)

[Los sesgos que engañan al cerebro durante la pandemia, El País](https://elpais.com/ciencia/2020-03-26/los-sesgos-que-enganan-al-cerebro-durante-la-pandemia.html) 

[The Ibuprofen Debate Reveals the Danger of Covid-19 Rumors](https://www.wired.com/story/the-ibuprofen-debate-reveals-the-danger-of-covid-19-rumors/) 

[Rockefeller-Led Team Launches Initiative to Study COVID-19 Genetic Vulnerability (GenomeWeb)](https://www.genomeweb.com/infectious-disease/rockefeller-led-team-launches-initiative-study-covid-19-genetic-vulnerability)

[El Cabildo de Tenerife aporta una máquina de análisis de COVID-19](http://www.diariodetenerife.info/el-cabildo-de-tenerife-aporta-una-maquina-de-analisis-de-covid-19-que-hace-50-pruebas-por-hora/)

[Investigadores del ITER y de La Candelaria aceleran el método de diagnóstico del Covid-19](http://www.diariodetenerife.info/investigadores-del-iter-y-de-la-candelaria-aceleran-el-metodo-de-diagnostico-del-covid-19/)

[COVID-19: Why we should all wear masks — There is new scientific rationale](https://medium.com/@Cancerwarrior/covid-19-why-we-should-all-wear-masks-there-is-new-scientific-rationale-280e08ceee71)

[Over 24,000 coronavirus research papers are now available in one place](https://www.technologyreview.com/s/615367/coronavirus-24000-research-papers-available-open-data/)

[How sewage could reveal true scale of coronavirus outbreak](https://www.nature.com/articles/d41586-020-00973-x)

[Why It’s So Freaking Hard To Make A Good COVID-19 Model](https://fivethirtyeight.com/features/why-its-so-freaking-hard-to-make-a-good-covid-19-model/)

[NYT, Bad News Wrapped in Protein: Inside the Coronavirus Genome](https://www.nytimes.com/interactive/2020/04/03/science/coronavirus-genome-bad-news-wrapped-in-protein.html)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Protocols"></a>
## Protocols ##

[Shared SARS-COV-2 DIAGNOSTIC PIPELINES at FinDX](https://www.finddx.org/covid-19/pipeline/)
<p align="center">
    <a href="https://www.finddx.org/covid-19/pipeline/" title="See this resource">
      <img src="https://www.finddx.org/wp-content/themes/find/img/logo_header.svg" width="15%"/>
    </a> 
</p>

[WHO Coronavirus disease (COVID-19) technical guidance: Laboratory testing for 2019-nCoV in humans (Updated March 25, 2020)](https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance) [In-house developed molecular assays, not validated, probably still under development, but not necessarily updated here](https://www.who.int/docs/default-source/coronaviruse/whoinhouseassays.pdf?sfvrsn=de3a76aa_2)

<ul>
<li>
<a href="http://ivdc.chinacdc.cn/kyjz/202001/t20200121_211337.html" title="See this resorce">China CDC Primers and probes for detection 2019-nCoV (24 January 2020)</a>
  </li>
<li>
<a href="https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2" title="See this resorce">Diagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR – Charité, Berlin Germany (17 January 2020)</a>
  </li>
<li>
<a href="https://www.who.int/docs/default-source/coronaviruse/peiris-protocol-16-1-20.pdf?sfvrsn=af1aac73_4" title="See this resorce">Detection of 2019 novel coronavirus (2019-nCoV) in suspected human cases by RT-PCR – Hong Kong University (23 January 2020)</a>
  </li>
<li>
<a href="https://www.who.int/docs/default-source/coronaviruse/conventional-rt-pcr-followed-by-sequencing-for-detection-of-ncov-rirl-nat-inst-health-t.pdf?sfvrsn=42271c6d_4" title="See this resorce">PCR and sequencing protocol for 2019-nCoV - Department of Medical Sciences, Ministry of Public Health, Thailand (Updated 28 January 2020)</a>
  </li>
<li>
<a href="https://www.who.int/docs/default-source/coronaviruse/method-niid-20200123-2.pdf?sfvrsn=fbf75320_7" title="See this resorce">PCR and sequencing protocols for 2019-nCoV- National Institute of Infectious Diseases Japan (24 January 2020)</a>
  </li>
<li>
<a href="https://www.fda.gov/media/134922/download" title="See this resorce">US CDC Real-Time RT-PCR Panel for Detection 2019-Novel Coronavirus (28 January 2020)</a>
  </li>
<li>
<a href="https://www.who.int/docs/default-source/coronaviruse/uscdcrt-pcr-panel-primer-probes.pdf?sfvrsn=fa29cb4b_2" title="See this resorce">US CDC panel primer and probes– U.S. CDC, USA (28 January 2020)</a>
  </li>
<li>
<a href="https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf?sfvrsn=3662fcb6_2" title="See this resorce">Real-time RT-PCR assays for the detection of SARS-CoV-2 Institut Pasteur, Paris (2 March 2020)</a>
  </li>
</ul>
  
[Broad Institute](https://www.broadinstitute.org/files/publications/special/COVID-19%20detection%20(updated).pdf) 

[Analytical sensibility and specificity of two RT-qPCR protocols for SARS-CoV-2 detection performed in an automated workflow](https://www.medrxiv.org/content/10.1101/2020.03.07.20032326v1) 

[NIID Japan](https://www.niid.go.jp/niid/en/2019-ncov-e/9334-ncov-vir3-2.html)
[Detection of second case of 2019-nCoV infection in Japan](https://www.niid.go.jp/niid/en/examination.html)

[USA CDC Center for Disease and Control Coronavirus Disease 2019 (COVID-19)](https://www.cdc.gov/coronavirus/2019-ncov/lab/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Flab%2Frt-pcr-detection-instructions.html) 
[RT-PCR protocol](https://www.fda.gov/media/134922/download) 

[Chinese Center for Disease and Control and Prevention](http://www.chinacdc.cn/en/COVID19/)
[China CDC Real-time RT-PCR protocol](http://www.chinacdc.cn/en/COVID19/202003/P020200323390496137554.pdf)

[SwabSeq. Allows for detection of SARS-COV-2 genomic RNA, without purification, in a single-step RT-PCR followed by sequencing. By OctanBio](https://github.com/octantbio/SwabSeq)

[A Massively Parallel COVID-19 Diagnostic Assay for Simultaneous Testing of 19200 Patient Samples, in Twitter](https://twitter.com/hsalis/status/1241121806473461760?s=20)  | [Protocol](https://t.co/x2c2v8uvw3?amp=1) | [Primers & Spike-in Controls](https://t.co/9cWzQrfz5P?amp=1)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Rapid Tests"></a>
## Rapid Tests ##
> Section to highlight contributions to rapid tests production and testing.

[Fast, portable tests come online to curb coronavirus pandemic, Nature. See table inside](https://www.nature.com/articles/d41587-020-00010-2)

[COVID-19: immunopathology and its implications for therapy](https://www.nature.com/articles/s41577-020-0308-3)

[Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies](https://www.medrxiv.org/content/10.1101/2020.04.10.20061150v1)

[Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative Review](https://annals.org/aim/fullarticle/2764737/diagnostic-testing-severe-acute-respiratory-syndrome-related-coronavirus-2-narrative)


<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- SECTION -->

<a name="Research Coalitions and Funding Calls"></a>
## Research Coalitions and Funding Calls ##
> Section to collect open calls in the research funding arena.

[COVID-19 Clinical Research Coalition](https://covid19crc.org/)

[COVID-Zero Coalition](https://wellcome.ac.uk/what-we-do/our-work/coronavirus-covid-19/investment/covid-zero)

[COVID Human Genetic Effort](https://www.covidhge.com/)
<p align="center">
    <a href="https://www.covidhge.com/">
      <img src="https://images.squarespace-cdn.com/content/v1/5e7bb93fa060854b1a204f9a/1585618859125-Q41LFBN0HJ30OTPJC2FT/ke17ZwdGBToddI8pDm48kHf62bRcj8g5xu3PjqRtWb5Zw-zPPgdn4jUwVcJE1ZvWQUxwkmyExglNqGp0IvTJZUJFbgE-7XRK3dMEBRBhUpzVvhhfg18jv7JFa1V4i-BVDEgkDMV135pHH45GHFhanv1h3j41qTAPGVXHKsjsg_U/COVID+Human+Genetic+Effort+Logo?format=750w" width="20%"/>
    </a> 
</p>

[WHO The Global Preparedness Monitoring Board](https://apps.who.int/gpmb/)

[CaixaImpulse COVID-19 Call for projects that address the COVID-19 emergency open until 15 April](https://caixaimpulse.com/programme?program_id=PROGRAMME_COVID_19)

[European Comission Funding & tender opportunities Single Electronic Data Interchange Area (SEDIA)](https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/covid-19)

[European Research Council List of ERC-funded Research Projects related to coronavirus](https://erc.europa.eu/list-erc-funded-research-projects-related-coronavirus)

[European Comission Coronavirus research and innovation. Research and innovation projects and initiatives to tackle the spread of coronavirus and preparedness for other outbreaks](https://ec.europa.eu/info/research-and-innovation/research-area/health-research-and-innovation/coronavirus-research_en)

[Solicitud urgente de Expresiones de Interés para la financiacin extraordinaria de proyectos de investigacin sobre el SARS-CoV-2 y la enfermedad COVID-19, Ministerio de Ciencia e Innovacin, España](https://www.isciii.es/QueHacemos/Financiacion/Paginas/SolicitudExpresionesInteresCoVid19.aspx#new_tab?utm_source=rss&utm_medium=rss&utm_campaign=solicitud-urgente-de-expresiones-de-interes-para-la-financiacion-extraordinaria-de-proyectos-de-investigacion-sobre-el-sars-cov-2-y-la-enfermedad-covid19)

[Fast Funding for COVID-19 Science](https://fastgrants.org/)

[The Open COVID Pledge](https://opencovidpledge.org/)
<p align="center">
    <a href="https://opencovidpledge.org/" title="See this resource">
      <img src="https://opencovidpledge.org/wp-content/uploads/OCP_Logos/cropped-OCP_WP_logo_240x240.png" width="20%"/>
    </a> 
</p>

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Respirators, masks, and other Personal Protective Equipments (PPE)"></a>
## Respirators, masks, and other Personal Protective Equipments (PPE)
> A selection of websites to understand what a respirator or a mask is, and what are the differences between the different personal protective equipments.

[N95 Respirators and Surgical Masks (Face Masks)](https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-and-surgical-masks-face-masks)

[Comparison of nanoparticle filtration performance of NIOSH-approved and CE-marked particulate filtering facepiece respirators](https://www.ncbi.nlm.nih.gov/pubmed/19261695)

[Comparison of FFP2, KN95, and N95 and Other Filtering Facepiece Respirator Classes](https://multimedia.3m.com/mws/media/1791500O/comparison-ffp2-kn95-n95-filtering-facepiece-respirator-classes-tb.pdf) 

[Ventilators are in high demand for Covid-19 patients. How do they work?](https://www.statnews.com/2020/03/30/covid-19-ventilators-how-they-work/)

[Guías para la fabricación de mascarillas y ropa de protección, Ministerio de Sanidad](https://www.mincotur.gob.es/es-es/COVID-19/Paginas/guias-para-fabricacion-de-mascarillas-y-ropa-de-proteccion.aspx)

[Clarificación de los diferentes tipos de mascarillas, Ministerio de Sanidad](https://www.redaccionmedica.com/contenido/images/1_clarificacion_diferentes_tipos_mascarillas.pdf)

[Marcado CE de las mascarillas, Ministerio de Industrial, Comercio y Turismo](https://www.mincotur.gob.es/es-es/COVID-19/GuiaFabricacionEPIs/2_mascarillas_tipo_EPI_como_legalizarlas_v2.0.pdf)

[Widespread use of face masks in public may slow the spread of SARS CoV-2: an ecological study](https://www.medrxiv.org/content/10.1101/2020.03.31.20048652v1)

[Face mask use in the general population and optimal resource allocation during the COVID-19 pandemic](https://www.medrxiv.org/content/10.1101/2020.04.04.20052696v1)

[Efficacy of face mask in preventing respiratory virus transmission: a systematic review and meta-analysis](https://www.medrxiv.org/content/10.1101/2020.04.03.20051649v1)

[Can N95 respirators be reused after disinfection? And for how many times?](https://www.medrxiv.org/content/10.1101/2020.04.01.20050443v1)

[N95 Mask Decontamination using Standard Hospital Sterilization Technologies](https://www.medrxiv.org/content/10.1101/2020.04.05.20049346v1)

[UV light dosage distribution over irregular respirator surfaces. Methods and implications for safety](https://www.medrxiv.org/content/10.1101/2020.04.07.20057224v1)

[Nonmedical Masks in Public for Respiratory Pandemics: Droplet Retention by two-layer Textile Barrier Fully Protects Germ-free Mice from Bacteria in Droplets](https://www.biorxiv.org/content/10.1101/2020.04.06.028688v1)

[Physical interventions to interrupt or reduce the spread of respiratory viruses. Part 1 - Face masks, eye protection and person distancing: systematic review and meta-analysis](https://www.medrxiv.org/content/10.1101/2020.03.30.20047217v2)

[Face Masks Against COVID-19: An Evidence Review](https://www.preprints.org/manuscript/202004.0203/v1)

[Assessment of N95 respirator decontamination and re-use for SARS-CoV-2](https://www.medrxiv.org/content/10.1101/2020.04.11.20062018v1)

[Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity](https://www.medrxiv.org/content/10.1101/2020.04.11.20062331v1)

[Publicada la Especificación UNE para facilitar la fabricación de mascarillas higiénicas reutilizables](https://www.une.org/la-asociacion/sala-de-informacion-une/noticias/especificacion-une-mascarillas)     |     [Descarga directa de PDF](https://www.mincotur.gob.es/es-es/COVID-19/GuiaFabricacionEPIs/Especificacion%20UNE%20Mascarillas%20higienicas%20reutilizables/Especificacion_UNE_0065_mascarillas_higienicas_reutilizables.pdf)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Scientific Communications and Literature (Pre-prints & Peer-Reviewed Papers)"></a>
## Scientific Communications and Literature (Pre-prints & Peer-Reviewed Papers)
> Reminder. Notice that a number of these papers might be preliminary reports that have not been peer-reviewed. 
> They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.
<br />

[COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv](https://connect.medrxiv.org/relate/content/181)
<p align="center">
    <a href="https://connect.medrxiv.org/relate/content/181" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/medRxiv-bioRxiv.png" width="40%"/>
    </a> 
</p>

[NEJM Jornal Watch](https://www.jwatch.org/covid-19)

[Coronavirus: Research, Commentary, and News | Science | AAAS](https://www.sciencemag.org/collections/coronavirus)

[COVID-19 Preprints](https://covid19preprints.app/)

[REACTing research & action targeting emerging infectious diseases web portal. Selection of the most relevant articles published on COVID-19 on a bi-weekly basis. France](https://reacting.inserm.fr/literature-review/)

[SemanticScholar COVID-19 Open Research Dataset (CORD-19)](https://pages.semanticscholar.org/coronavirus-research)
<p align="center">
    <a href="https://pages.semanticscholar.org/coronavirus-research" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/CORD-19.png" width="40%"/>
    </a> 
</p>

[Early warnings of novel coronavirus from genomic epidemiology and the global open scientific response](https://bedford.io/blog/genomic-epi-for-ncov-response/) 

[A Novel Coronavirus from Patients with Pneumonia in China, 2019](https://www.nejm.org/doi/10.1056/NEJMoa2001017) 

[Novel 2019 coronavirus genome](http://virological.org/t/novel-2019-coronavirus-genome/319) 

[Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia](https://www.nejm.org/doi/full/10.1056/NEJMoa2001316) 

[Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1](https://www.nejm.org/doi/full/10.1056/NEJMc2004973) 

[A pneumonia outbreak associated with a new coronavirus of probable bat origin](https://www.nature.com/articles/s41586-020-2012-7?WT.ec_id=NATURE-20200312) 

[Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases](https://pubs.acs.org/doi/10.1021/acscentsci.0c00272) 

[A new coronavirus associated with human respiratory disease in China](https://www.nature.com/articles/s41586-020-2008-3?WT.ec_id=NATURE-20200312) 

[Rational use of face masks in the COVID-19 pandemic](https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30134-X) 

[Three Emerging Coronaviruses in Two Decades
The Story of SARS, MERS, and Now COVID-19](https://academic.oup.com/ajcp/article/153/4/420/5735509) 

[Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding](https://www.sciencedirect.com/science/article/pii/S0140673620302518) 

[Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding](https://doi.org/10.1038/s41591-020-0817-4) 

[A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units](https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(20)30040-7/fulltext) 

[Managing neonates with respiratory failure due to SARS-CoV-2](https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(20)30073-0/fulltext) 

[Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30566-3/fulltext) 

[Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan,China](https://doi.org/10.1093/cid/ciaa272) 

[Coronavirus Disease 2019: Coronaviruses and Blood Safety](https://doi.org/10.1016/j.tmrv.2020.02.003) 

[COVID-19: what is next for public health?](https://doi.org/10.1016/S0140-6736(20)30374-3) 

[Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany](https://www.nejm.org/doi/full/10.1056/NEJMc2001468) 

[Understanding of COVID-19 based on current evidence](https://www.ncbi.nlm.nih.gov/pubmed/32096567) 

[Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1](https://www.nejm.org/doi/full/10.1056/NEJMc2004973) 

[Clinical Characteristics of Coronavirus Disease 2019 in China](https://www.nejm.org/doi/full/10.1056/NEJMoa2002032) 

[A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19](https://www.nejm.org/doi/full/10.1056/NEJMoa2001282) 

[CDC Coronavirus Disease 2019 (COVID-19) publications](https://www.cdc.gov/coronavirus/2019-ncov/publications.html) 

[Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia](https://academic.oup.com/clinchem/advance-article/doi/10.1093/clinchem/hvaa029/5719336) 

[NIID National Institute for Infectious Diseases Manual for the Detection of Pathogen 2019-nCoV](https://www.niid.go.jp/niid/en/examination/9493-labmanual-en.html) 

[Coronavirus Disease 2019 (COVID-19) in Italy](https://jamanetwork.com/journals/jama/fullarticle/2763401) 

[Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy](https://jamanetwork.com/journals/jama/fullarticle/2763667) 

[Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy. Early Experience and Forecast During an Emergency Response](https://jamanetwork.com/journals/jama/fullarticle/2763188)

[Detection of SARS-CoV-2 in Different Types of Clinical Specimens](https://jamanetwork.com/journals/jama/fullarticle/2762997) 

[OVID-19 in Singapore—Current Experience: Critical Global Issues That Require Attention and Action](https://jamanetwork.com/journals/jama/fullarticle/2761890)

[Coronavirus Disease 2019 and Influenza](https://jamanetwork.com/journals/jama/fullarticle/2762386) 

[Coronavirus Infections—More Than Just the Common Cold](https://jamanetwork.com/journals/jama/fullarticle/2759815) 

[Direct RNA nanopore sequencing of full-length coronavirus genomes provides novel insights into structural variants and enables modification analysis](https://europepmc.org/article/MED/31439691) 

[Diagnosis of Acute Respiratory Syndrome Coronavirus 2 Infection by Detection of Nucleocapsid Protein](https://www.medrxiv.org/content/10.1101/2020.03.07.20032524v2)

[Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30566-3/fulltext)

[Transcriptional Inhibition of Host Viral Entry Proteins as a Therapeutic Strategy for SARS-CoV-2](https://www.preprints.org/manuscript/202003.0360/v1)

[Human leukocyte antigen susceptibility map for SARS-CoV-2](https://www.medrxiv.org/content/10.1101/2020.03.22.20040600v1)

[An international comparison of the second derivative of COVID-19 deaths after implementation of social distancing measures](https://www.medrxiv.org/content/10.1101/2020.03.25.20041475v1)

[Estimating the number of infections and the impact of nonpharmaceutical interventions on COVID-19 in 11 European countries](https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-Europe-estimates-and-NPI-impact-30-03-2020.pdf)

[Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-2](https://www.biorxiv.org/content/10.1101/2020.03.30.015347v1)

[Clinical and virological data of the first cases of COVID-19 in Europe: a case series](https://www.sciencedirect.com/science/article/pii/S1473309920302000?via%3Dihub)

[SARS-CoV-2 detection from nasopharyngeal swab samples without RNA extraction](https://www.biorxiv.org/content/10.1101/2020.03.28.013508v1)

[Nature Special Report. Special report: The simulations driving the world’s response to COVID-19. How epidemiologists rushed to model the coronavirus pandemic](https://www.nature.com/articles/d41586-020-01003-6)

[Respiratory virus shedding in exhaled breath and efficacy of face masks](https://www.nature.com/articles/s41591-020-0843-2)

[SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation](https://www.biorxiv.org/content/10.1101/2020.04.01.021196v1)

[Virological assessment of hospitalized patients with COVID-2019](https://www.nature.com/articles/s41586-020-2196-x)

[Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins](https://www.nature.com/articles/s41586-020-2169-0)

[Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection](https://www.biorxiv.org/content/10.1101/2020.04.02.022764v2)

[Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing](https://pubs.rsna.org/doi/10.1148/radiol.2020200343)

[Is low dose radiation therapy a potential treatment for COVID-19 pneumonia?](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30304-4/fulltext)

[Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test](https://www.medrxiv.org/content/10.1101/2020.03.26.20044222v1)

[The convalescent sera option for containing COVID-19](https://www.jci.org/articles/view/138003/pdf)

[Novel Coronavirus Infection in Newborn Babies Under 28 Days in China](https://erj.ersjournals.com/content/early/2020/04/01/13993003.00697-2020)

[A case of SARS-CoV-2 carrier for 32 days with several times false negative nucleic acid tests](https://www.medrxiv.org/content/10.1101/2020.03.31.20045401v1)

[Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection](https://www.medrxiv.org/content/10.1101/2020.04.05.20048421v1)

[Toilets dominate environmental detection of SARS-CoV-2 virus in a hospital](https://www.medrxiv.org/content/10.1101/2020.04.03.20052175v1)

[Validation of a Lysis Buffer Containing 4 M Guanidinium Thiocyanate (GITC)/ Triton X-100 for Extraction of SARS-CoV-2 RNA for COVID-19 Testing: Comparison of Formulated Lysis Buffers Containing 4 to 6 M GITC, Roche External Lysis Buffer and Qiagen RTL Lysis Buffer](https://www.medrxiv.org/content/10.1101/2020.04.05.20049346v1)

[An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice](https://stm.sciencemag.org/content/early/2020/04/03/scitranslmed.abb5883)

[Estimation of the percentages of asymptomatic patients and undiagnosed patients of the novel coronavirus (SARS-CoV-2) infection in Hokkaido, Japan by using birth-death process with recursive full tracing](https://www.medrxiv.org/content/10.1101/2020.04.06.20053934v1)

[Blueprint for a Pop-up SARS-CoV-2 Testing Lab](https://www.medrxiv.org/content/10.1101/2020.04.11.20061424v1)

[Cutaneous manifestations in COVID‐19: a first perspective](https://onlinelibrary.wiley.com/doi/10.1111/jdv.16387)

[Dermatology staff participate in fight against Covid-19 in China](https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.16390)

[Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations](https://wwwnc.cdc.gov/eid/article/26/7/20-0839_article)

[Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir](https://www.biorxiv.org/content/10.1101/2020.04.08.032763v2)

[Universal Screening for SARS-CoV-2 at Delivery Could Identify Many Asymptomatic Women](https://www.nejm.org/doi/full/10.1056/NEJMc2009316)

[Stability of the COVID-19 virus under wet, dry and acidic conditions](https://www.medrxiv.org/content/10.1101/2020.04.09.20058875v1)

[Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020](https://doi.org/10.3201/eid2607.200885)

[Spread of SARS-CoV-2 in the Icelandic Population](https://www.nejm.org/doi/full/10.1056/NEJMoa2006100)

[Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)](https://science.sciencemag.org/content/early/2020/03/24/science.abb3221)

[Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens](https://jamanetwork.com/journals/jama/fullarticle/2764787)

[Exploring possible mechanisms for COVID‐19 induced thrombocytopenia: Unanswered Questions](https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.14832)

[Structure of the RNA-dependent RNA polymerase from COVID-19 virus](https://science.sciencemag.org/content/early/2020/04/09/science.abb7498)

[Temporal dynamics in viral shedding and transmissibility of COVID-19](https://www.nature.com/articles/s41591-020-0869-5)


<!--
[]()
[]()
[]()
[]()
[]()
[]()
[]()
-->

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- ------------------ SUBSECTION ------------------ -->

<a name="Maths and Epidemiological Models"></a>
## Maths and Epidemiological Models
> Subsection dedicated to PCR (RT-qPCR) and related topics.
<br />

[Modelo para el estudio de la dinámica de transmisión del SARS-CoV-2 y la enfermedad COVID19. Descripción técnica](https://covid19.webs.upv.es/INFORMES/Explicacion_tecnica.pdf)

[The use of facemasks to prevent respiratory infection: a literature review in the context of the Health Belief Model](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293989/)

[Reproductive numbers, epidemic spread and control in a community of households](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731010/)

[Mathematical Modeling of the Effectiveness of Facemasks in Reducing the Spread of Novel Influenza A (H1N1)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818714/)

[The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Germany, 2009-2011](https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-12-26)

[Mask use, hand hygiene, and seasonal influenza-like illness among young adults: A randomized intervention trial](https://academic.oup.com/jid/article/201/4/491/861190)

[Unraveling R0: Considerations for Public Health Applications](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935673/)

[The Immediate Effect of COVID-19 Policies on Social Distancing Behavior in the United States](https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3571421)

[Flattening the curve before it flattens us: hospital critical care capacity limits and mortality from novel coronavirus (SARS-CoV2) cases in US counties - 3 and 6 week projections from April 2, 2020](https://behcolumbia.files.wordpress.com/2020/04/flattening-the-curve-before-it-flattens-us-20200405b.pdf)

[Sustainable social distancing through facemask use and testing during the Covid-19 pandemic](https://www.medrxiv.org/content/10.1101/2020.04.01.20049981v1)

[Swiss Medical Weekly - Potential impact of seasonal forcing on a SARS-CoV-2 pandemic](https://doi.org/10.4414/smw.2020.20224)

[Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period](https://science.sciencemag.org/content/early/2020/04/14/science.abb5793)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- ------------------ SUBSECTION ------------------ -->

<a name="PCR related articles"></a>
## PCR related articles and other detection techniques

> Subsection dedicated to PCR (RT-qPCR) and related topics.
<br />

[Combination of RT‐qPCR testing and clinical features for diagnosis of COVID‐19 facilitates management of SARS‐CoV‐2 outbreak](https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25721)

[Positive RT-PCR Test Results in Patients Recovered From COVID-19](https://jamanetwork.com/journals/jama/fullarticle/2762452) 

[Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR](https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045) 

[RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swab using Qiagen RNEasy kits or directly via omission of an extraction step](https://www.biorxiv.org/content/10.1101/2020.03.20.001008v1) 

[DIRECT RT-qPCR DETECTION OF SARS-CoV-2 RNA FROM PATIENT NASOPHARYNGEAL SWABS WITHOUT AN RNA EXTRACTION STEP](https://www.biorxiv.org/content/10.1101/2020.03.20.001008v2)

[Analytical sensibility and specificity of two RT-qPCR protocols for SARS-CoV-2 detection performed in an automated workflow](https://www.medrxiv.org/content/10.1101/2020.03.07.20032326v1)

[Portable and accurate diagnostics for COVID-19: Combined use of the miniPCR thermocycler and a well-plate reader for SARS-Co2 virus detection](https://www.medrxiv.org/content/10.1101/2020.04.03.20052860v1)

[Reverse-transcription quantitative PCR directly from cells without RNA extraction and without isothermal reverse-transcription: a ‘zero-step’ RT-qPCR protocol](https://academic.oup.com/biomethods/article/2/1/bpx008/3858804)

[Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR](https://www.medrxiv.org/content/10.1101/2020.04.05.20053355v1)

[Efficient and Practical Sample Pooling High-Throughput PCR Diagnosis of COVID-19](https://www.medrxiv.org/content/10.1101/2020.04.06.20052159v1)

[The Potential Use of Unprocessed Sample for RT-qPCR Detection of COVID-19 without an RNA Extraction Step](https://www.biorxiv.org/content/10.1101/2020.04.06.028811v1)

[Optimization of SARS-CoV-2 detection by RT-QPCR without RNA extraction](biorxiv.org/cgi/content/short/2020.04.06.028902)

[Variation in False Negative Rate of RT-PCR Based SARS-CoV-2 Tests by Time Since Exposure](https://www.medrxiv.org/content/10.1101/2020.04.07.20051474v1)

[Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19](https://mbio.asm.org/content/11/2/e00722-20)

[Rapid colorimetric detection of COVID-19 coronavirus using a reverse tran-scriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic plat-form: iLACO](https://www.medrxiv.org/content/10.1101/2020.02.20.20025874v1)

[Non-specific Primers Reveal False-negative Risk in Detection of COVID-19 Infections](https://www.medrxiv.org/content/10.1101/2020.04.07.20056804v1)

[Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples](https://www.medrxiv.org/content/10.1101/2020.04.08.20058495v1)

[Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19)](http://www.en-journal.org/journal/view.html?doi=10.5607/en20009)

[An alternative workflow for molecular detection of SARS-CoV-2 - escape from the NA extraction kit-shortage](https://www.medrxiv.org/content/10.1101/2020.03.27.20044495v1)

[High-throughput extraction of SARS-CoV-2 RNA from nasopharyngeal swabs using solid-phase reverse immobilization beads](https://www.medrxiv.org/content/10.1101/2020.04.08.20055731v1)

[A streamlined approach to rapidly detect SARS-CoV-2 infection, avoiding RNA extraction](https://www.medrxiv.org/content/10.1101/2020.04.06.20054114v1)

[SARS-CoV-2 detection with CRISPR diagnostics](https://www.biorxiv.org/content/10.1101/2020.04.10.023358v1)

[Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP](https://www.medrxiv.org/content/10.1101/2020.02.26.20028373v1)

[Analysis of factors associated early diagnosis in coronavirus disease 2019 (COVID-19)](https://www.medrxiv.org/content/10.1101/2020.04.09.20059352v1)

[COVID-19 Protocolo - Grupo de investigación Neuronal Ubiquitin Pathways - UPV/EHU](https://www.ehu.eus/es/web/umayor/covid-19-protocol)

[A protocol for massively parallel diagnosis and genome sequencing of SARS-CoV-](https://www.protocols.io/view/a-protocol-for-massively-parallel-diagnosis-and-ge-betrjem6)

[A simple colorimetric molecular detection of novel coronavirus (COVID-19), an essential diagnostic tool for pandemic screening](https://www.medrxiv.org/content/10.1101/2020.04.10.20060293v1)

[Rapid diagnosis of SARS-CoV-2 infection by detecting IgG and IgM antibodies with an immunochromatographic device: a prospective single-center study](https://www.medrxiv.org/content/10.1101/2020.04.11.20062158v1)


<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Sciencific Data and Resources"></a>
## Sciencific Data and Resources ##
[2019 Novel Coronavirus COVID-19 (2019-nCoV) Data Repository by Johns Hopkins CSSE](https://github.com/CSSEGISandData/COVID-19)
<p align="center">
  <a href="https://github.com/CSSEGISandData/COVID-19" title="See this resource">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/JHU-CSSE_dashboard.png" width="40%" />
  </a>
</p>

[Nextstrain. Real-time tracking of pathogen evolution](https://nextstrain.org/)
<p align="center">
  <a href="https://nextstrain.org/" title="See this resource">
    <img src="https://nextstrain.org/dist/ea8c3e13e8c17436264760d638ab970e.png" width="10%" />
  </a>
</p>

[Artic Network](https://artic.network/ncov-2019)
<p align="center">
    <a href="https://artic.network/ncov-2019" title="See this resource">
      <img src="https://artic.network/assets/images/artic-logo-sticker.png" width="10%" />
    </a> 
</p>

[GISAID](https://www.gisaid.org/)
<p align="center">
    <a href="https://www.gisaid.org/" title="See this resource">
      <img src="https://www.gisaid.org/fileadmin/gisaid/img/schild.png" width="20%"/>
    </a> 
</p>

[NCBI SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) Sequences](https://www.ncbi.nlm.nih.gov/genbank/sars-cov-2-seqs/)

[Virological](http://virological.org/)
<p align="center">
    <a href="http://virological.org/" title="See this resource">
      <img src="http://virological.org/uploads/default/original/1X/7897c4e655617c4b6fe71a98eaa97a38778f0623.png" width="20%"/>
    </a> 
</p>

[National Genomics Data Center, Beijing Institute of Genomics, Chinese Academy of Sciences](https://bigd.big.ac.cn/ncov/v2?lang=en) [Released genomes](https://bigd.big.ac.cn/ncov/release_genome)
<p align="center">
    <a href="https://bigd.big.ac.cn/ncov/v2?lang=en" title="See this resource">
      <img src="https://bigd.big.ac.cn/static/image/nsti.png" width="20%"/>
    </a> 
</p>

[EMBL-EBI COVID-19 Portal](https://www.ebi.ac.uk/covid-19)
<p align="center">
    <a href="https://www.ebi.ac.uk/covid-19" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/EMBL-EBI-COVID19.png" width="30%"/>
    </a> 
</p>

[Coronavirus Structural Task Force](https://github.com/thorn-lab/coronavirus_structural_task_force)

[SWISSMODEL homology models](http://www.rcsb.org/news?year=2020&article=5e3c4bcba5007a04a313edcc)

[Nanopore (ONT) Novel Coronavirus information(COVID-19)](https://nanoporetech.com/about-us/news/novel-coronavirus-covid-19-information-and-updates)
<p align="center">
    <a href="https://nanoporetech.com/about-us/news/novel-coronavirus-covid-19-information-and-updates" title="See this resource">
      <img src="https://nanoporetech.com/themes/custom/nanopore/images/ont-logo.svg" width="40%"/>
    </a> 
</p>

[Clustering COVID-19 research papers](https://gclen.github.io/covid19-kaggle/plots/umap_covid-19_interactive.html)

[Análisis de los datos de COVID-19 en España, por Z Data Labs](https://zzdatalabs.com/coronavirus-es/)
<p align="center">
    <a href="https://zzdatalabs.com/coronavirus-es/" title="See this resource">
      <img src="https://zzdatalabs.com/wp-content/uploads/2019/07/Extended_headerAsset-21.png" width="40%"/>
    </a> 
</p>

[COVID-19 3D visualizer](https://www.covidvisualizer.com/)
<p align="center">
    <a href="https://www.covidvisualizer.com/" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/covidvisualizer.com.png" width="30%"/>
    </a> 
</p>

[Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)](https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6)

[Uniform analysis of coronavirus and SARS-COV-2 nanopore direct RNA sequencing datasets using MasterOfPores](https://biocorecrg.github.io/covid/)

[European Centre for Disease Prevention and Control](https://data.europa.eu/euodp/en/data/dataset/covid-19-coronavirus-data)
[European Centre for Disease Prevention and Control, data](https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide)
<p align="center">
    <a href="https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide" title="See this resource">
      <img src="https://data.europa.eu/euodp/sites/all/themes/openDataPortalTheme/images/odp_en.png" width="40%"/>
    </a> 
</p>

[European Data Portal, data for Spain, Evolución de enfermedad por el coronavirus (COVID-19)](https://www.europeandataportal.eu/data/datasets?locale=en&query=covid%20&page=1&country=es)
<p align="center">
    <a href="https://www.europeandataportal.eu/data/datasets?locale=en&query=covid%20&page=1&country=es" title="See this resource">
      <img src="https://data.europa.eu/euodp/sites/all/themes/openDataPortalTheme/images/odp_en.png" width="40%"/>
    </a> 
</p>

[IHME, Institute for Health Metrics and Evaluation, USA data](https://covid19.healthdata.org/projections?sfns=mo)
<p align="center">
    <a href="https://covid19.healthdata.org/projections?sfns=mo" title="See this resource">
      <img src="https://covid19.healthdata.org/dist/images/ihme-logo.svg" width="30%"/>
    </a> 
</p>

<hr>

[Ministerio de Sanidad, España](https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/home.html)
<br>
<p align="center">
    <a href="https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/home.html" title="See this resource">
      <img src="https://www.mscbs.gob.es/diseno/img/BANER-CORONAVIRUS-900X100.jpg" width="60%"/>
    </a> 
</p>

[Informes MoMo (Sistema de Monitorización de la Mortalidad Diaria (Sistema MoMo) del Instituto de Salud Carlos III](https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/MoMo/Paginas/Informes-MoMo-2020.aspx)
<p align="center">
    <a href="https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/MoMo/Paginas/Informes-MoMo-2020.aspx" title="See this resource">
      <img src="https://www.isciii.es/Style%20Library/ISCIII.Portal/imagenes/LogoISCIII.svg" width="40%"/>
    </a> 
</p>

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

[Instituto de Matemática Interdisciplinar de la Universitat Politécnica de Valencia (UPV) Modelling Uncertainty Quantification, Reports in PDF](https://www.imm.upv.es/covid-19/) [Modelización epidemiolgica: Informes](https://covid19.webs.upv.es/informes.html)

<p align="center">
    <a href="https://www.imm.upv.es/covid-19/" title="See this resource">
      <img src="http://covid19.webs.upv.es/IMAGENES/prueba3.png" width="50%"/>
    </a> 
</p>

[Bioinformatics Unit of Instituto de Salud Carlos III (Spain)](https://github.com/BU-ISCIII/SARS-Cov2_analysis) 

<p align="center">
    <a href="https://github.com/BU-ISCIII/SARS-Cov2_analysis" title="See this resource">
      <img src="https://github.com/BU-ISCIII/SARS-Cov2_analysis/blob/master/BU_ISCIII_logo.png" width="30%"/>
    </a> 
</p>

[SARS-CoV-2 Galaxy Project](https://github.com/galaxyproject/SARS-CoV-2) 
<p align="center">
    <a href="https://github.com/galaxyproject/SARS-CoV-2" title="See this resource">
      <img src="https://raw.githubusercontent.com/galaxyproject/SARS-CoV-2/master/genomics/img/galaxy_logo.png" width="20%"/>
    </a> 
</p>

[COVID-19 scenarios](https://neherlab.org/covid19/) 

[Imperial College London reports](https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/) 

[COVID-19: on average only 6% of actual SARS-CoV-2 infections detected worldwide, University of Göttingen](http://www.uni-goettingen.de/de/document/download/3d655c689badb262c2aac8a16385bf74.pdf/Bommer%20&%20Vollmer%20(2020)%20COVID-19%20detection%20April%202nd.pdf)


[NIH Coronavirus Disease 2019 Situation Summary](https://www.nih.gov/health-information/coronavirus) 
<p align="center">
    <a href="https://www.nih.gov/health-information/coronavirus" title="See this resource">
      <img src="https://www.nih.gov/sites/all/themes/nih/images/nih-logo-color.png" width="30%"/>
    </a> 
</p>

[Bioinformatics resources for SARS-CoV-2](http://www.clinbioinfosspa.es/CovidResources) 

[Coronavirus analysis tools developed by scientists at the University of Tartu, Estonia](https://koroona.ut.ee/?lang=en)

[SARS-CoV-2 Sequencing Resources](https://github.com/CDCgov/SARS-CoV-2_Sequencing) 

[COVID-19 Open Research Dataset Challenge (CORD-19)](https://www.kaggle.com/allen-institute-for-ai/CORD-19-research-challenge) 
<p align="center">
    <a href="https://www.kaggle.com/allen-institute-for-ai/CORD-19-research-challenge" title="See this resource">
      <img src="https://www.kaggle.com/static/images/site-logo.png" width="20%"/>
    </a> 
</p>

[World-o-Meter](https://www.worldometers.info/coronavirus/) 
<p align="center">
    <a href="https://www.worldometers.info/coronavirus/" title="See this resource">
      <img src="https://www.worldometers.info/img/worldometers-logo.gif" width="30%"/>
    </a> 
</p>

[How many tests for COVID-19 are being performed around the world?](https://ourworldindata.org/covid-testing) 

[Epidemic Calculator](http://gabgoh.github.io/COVID/index.html) 
<p align="center">
    <a href="http://gabgoh.github.io/COVID/index.html" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/epidemic_calculator.png" width="30%"/>
    </a> 
</p>

[SARS-CoV-2 pathways](https://www.wikipathways.org/index.php/Portal:Disease/COVIDPathways) 
<p align="center">
    <a href="https://www.wikipathways.org/index.php/Portal:Disease/COVIDPathways" title="See this resource">
      <img src="https://www.wikipathways.org//skins/common/images/wplogo_125.png" width="20%"/>
    </a> 
</p>

[Evolución del coronavirus (COVID-19) en Euskadi](https://opendata.euskadi.eus/catalogo/-/evolucion-del-coronavirus-covid-19-en-euskadi/) 
<p align="center">
    <a href="https://opendata.euskadi.eus/catalogo/-/evolucion-del-coronavirus-covid-19-en-euskadi/" title="See this resource">
      <img src="https://opendata.euskadi.eus/images/w79-logo_opendata.gif" width="30%"/>
    </a> 
</p>

[CDC Morbidity and Mortality Weekly Report (MMWR) Novel Coronavirus Reports](https://www.cdc.gov/mmwr/Novel_Coronavirus_Reports.html) 

[COVID-19 R-shiny codes](https://github.com/topics/covid-19) 

[CDC Information for Laboratories RT-PCR resources](https://www.cdc.gov/coronavirus/2019-ncov/lab/index.html) 

[COVID-19 Tracker Shiny app in R](https://mentalbreaks.shinyapps.io/covid19/)

[United Against COVID-19](http://united-against-covid.org/)

[PolyMath COVID-19 dataset clearinghouse](http://michaelnielsen.org/polymath1/index.php?title=COVID-19_dataset_clearinghouse)

[Discourse Data Against Covid19](https://discourse.data-against-covid.org/)

[DataStudio International-Domestic spreading of 2019-nCoV-V4](https://datastudio.google.com/reporting/3ffd36c3-0272-4510-a140-39e288a9f15c/page/U5lCB)
<p align="center">
    <a href="https://datastudio.google.com/reporting/3ffd36c3-0272-4510-a140-39e288a9f15c/page/U5lC" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/International_Domestic_SpreadingCOVID-19.png" width="30%"/>
    </a> 
</p>

[CSVS Babelomics Collaborative Spanish Variant Server to visualize polimorphisms in the Spanish population in genes related with COVIDー19](https://twitter.com/CSVS_es/status/1244286199243603972)

[Jupyter R notebook for prediction modelling of Covid-19 data. Predictive modelling of 2019-nCov outbreak data in Canary Islands. Departamento de Matemáticas, Estadística e Investigación Operativa, ULL](https://github.com/ULL-STAT/covid19_model)
<p align="center">
    <a href="https://github.com/ULL-STAT/covid19_model" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/COVID-19_ULL.png" width="30%"/>
    </a> 
</p>

[Explore the Spread of Covid-19, Humboldt-Universität zu Berlin](https://trr266.wiwi.hu-berlin.de/shiny/tidycovid19/)

[COVID-19 Host Genetics Initiative](https://www.covid19hg.org/)

[The COVID Tracking Project, testing data available for US states and territories](https://covidtracking.com/)

[ETE team modeling group ( MIVEGEC Laboratory , CNRS, IRD, University of Montpellier)](http://bioinfo-shiny.ird.fr:3838/COVIDSIM/)

[MIDAS 2019 Novel Coronavirus Repository](https://github.com/midas-network/COVID-19)
<p align="center">
    <a target="_blank" href="https://github.com/midas-network/COVID-19" title="See this resource">
      <img src="https://raw.githubusercontent.com/midas-network/COVID-19/master/docs/MIDAS-4.png" width="20%"/>
    </a> 
</p>

[Dashboard del Sistema para la Vigilancia de la mortalidad diaria por todas las causas en España (Informe MoMo)](https://momo.isciii.es/public/momo/dashboard/momo_dashboard.html)
<p align="center">
    <a target="_blank" href="https://momo.isciii.es/public/momo/dashboard/momo_dashboard.html" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/MoMo-dashboard.png" width="30%"/>
    </a> 
</p>

[WHO updates COVID-19 dashboard with better data visualization](https://covid19.who.int/)

[Databriks data collection](https://databricks.com/blog/2020/04/14/covid-19-datasets-now-available-on-databricks.html)

[Datadista data on COVID-19](https://github.com/datadista/datasets/blob/master/COVID%2019/readme.md)

[CIVIO datos Pruebas PCR para detectar casos de coronavirus. Actualización diaria con el número (total y relativo) de PCR realizadas por comunidades autónomas para diagnosticar casos de covid-19](https://datos.civio.es/dataset/pcr-coronavirus-covid19-espana-comunidades-autonomas/)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>

<!-- ------------------ SUB-SECTION ------------------ -->
<a name="Autonomous Regions and Cities in Spain"></a>
> List of institutional websites for the governments of each of the Spanish Autonomous Regions (17) and Cities (2).

Autonomous Regions and Cities in Spain:
<ul>

<li>
<a href="https://www.aragon.es/coronavirus" title="See this resource">Aragón</a>
</li>

<li>
<a href="https://www.asturias.es/portal/site/webasturias/menuitem.4b280f8214549ead3e2d6f77f2300030/?vgnextoid=bae12eee144c0710VgnVCM10000097030a0aRCRD&vgnextchannel=d682d22a18b6e210VgnVCM1000002f030003RCRD&i18n.http.lang=es" title="See this resource">Principado de Asturias</a>
</li>

<li>
<a href="https://sanidad.castillalamancha.es/ciudadanos/enfermedades-infecciosas/coronavirus" title="See this resource">Castilla La Mancha</a>
<a href="https://sanidad.castillalamancha.es/ciudadanos/enfermedades-infecciosas/coronavirus/actualizacion-de-casos-en-castilla-la-mancha" title="See this resource">Datos</a>
</li>

<li>
  <a href="https://www.gobiernodecanarias.org/sanidad/scs/covid19" title="See this resource">Portal del GOBCAN con el seguimiento de la pandemia por SARS-Cov-2</a>
  <a href="https://www3.gobiernodecanarias.org/sanidad/scs/content/dcb400c5-6504-11ea-9a8e-719d4b52bf6c/InformeCasosCOVID-19.pdf" title="See this resource">Canarias. Informes epidemiológicos de Salud Pública de la Consejería de Sanidad del Gobierno Autónomo de Canarias</a>
  <a href="https://grafcan1.maps.arcgis.com/apps/opsdashboard/index.html#/156eddd4d6fa4ff1987468d1fd70efb6" >Dashboard with graphical information on COVID-19 incidence in the Canary Islands, by Grafcan-GOBCAN</a>
</li>

<li>
<a href="https://www.aspb.cat/documents/covid19-cast/" title="See this resource">Generalitat de Catalunya</a>
<a href="http://aquas.gencat.cat/ca/actualitat/ultimes-dades-coronavirus" title="See this resource">Datos</a>
</li>

<li>
<a href="http://saludcantabria.es/index.php?mact=News,cntnt01,detail,0&cntnt01articleid=2145&cntnt01origid=15&cntnt01returnid=289" title="See this resource">Cantabria</a>
</li>

<li>
<a href="https://www.ceuta.es/ceuta/index.php" title="See this resource">Ciudad Autónoma de Ceuta</a>
</li>

<li>
<a href="http://www.caib.es/sites/coronavirus/es/portada/" title="See this resource">Govern Illes Balears</a>
</li>

<li>
<a href="https://www.juntadeandalucia.es/organismos/saludyfamilias/areas/salud-vida/paginas/Nuevo_Coronavirus.html" title="See this resource">Junta de Andalucía</a>
</li>

<li>
<a href="http://www.juntaex.es/web/" title="See this resource">Junta de Extremadura</a>
</li>

<li>
<a href="https://coronavirus.sergas.gal/" title="See this resource">Xunta de Galicia</a>
</li>

<li>
<a href="https://analisis.datosabiertos.jcyl.es/pages/coronavirus/situacin-actual#situacin-actual" title="See this resource">Junta de Castilla y León. Situación epidemiológica del coronavirus en Castilla y León — Análisis de datos abiertos JCyL</a>
</li>

<li>
<a href="https://www.comunidad.madrid/servicios/salud/2019-nuevo-coronavirus" title="See this resource">Madrid</a> | <a href="https://datos.comunidad.madrid/catalogo/dataset/covid19_tia_zonas_basicas_salud" >Covid 19 -TIA Zonas Básicas de Salud - Conjuntos de datos - Datos Abiertos Comunidad de Madrid</a>
</li>

<li>
<a href="https://www.melilla.es/melillaPortal/index.jsp" title="See this resource">Ciudad Autónoma de Melilla</a>
</li>

<li>
<a href="https://www.navarra.es/es/web/coronavirus/inicio" title="See this resource">Navarra</a>
<a href="https://www.navarra.es/es/web/coronavirus/situacion-actua" title="See this resource">Datos</a>
</li>

<li>
<a href="https://www.osakidetza.euskadi.eus/inicio/" title="See this resource">País Vasco</a>
</li>

<li>
<a href="http://www.carm.es/web/pagina?IDCONTENIDO=106861&IDTIPO=10&RASTRO=c$m122,70" title="See this resource">Región de Murcia</a>
</li>

<li>
<a href="https://web.larioja.org/" title="See this resource">La Rioja</a>
</i>

<li>
<a href="http://infocoronavirus.gva.es/" title="See this resource">Generalitat Valenciana</a>
</li>

</ul>

[Casos de Covid-19 en España por Comunidades Autónomas, by CJP](https://public.flourish.studio/visualisation/1693192/)


<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Sequencing, Sequences and Bioinformatics"></a>
## Sequencing, Sequences and Bioinformatics ##
> Under construction. Soon here!

[NCBI GenBank SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) Sequences](https://www.ncbi.nlm.nih.gov/genbank/sars-cov-2-seqs/)

[NCBI GenBank Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome. GenBank: MN908947.3](https://www.ncbi.nlm.nih.gov/nuccore/MN908947)
<p align="center">
    <a href="https://www.ncbi.nlm.nih.gov/nuccore/MN908947" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/MN908947.3.png" width="40%"/>
    </a> 
</p>

[China National Center for Bioinformation (CNCB), 2019 Novel Coronavirus Resource](https://bigd.big.ac.cn/ncov/?lang=en)     |     [Genome Variation](https://bigd.big.ac.cn/ncov/variation)     |     [Data release statistics](https://bigd.big.ac.cn/ncov/release_genome)
<p align="center">
    <a href="https://bigd.big.ac.cn/ncov/?lang=en" title="See this resource">
      <img src="https://bigd.big.ac.cn/ncov/static/image/ncovr-logo.png" width="25%"/>
    </a> 
</p>

[Centre for Genomic Regulation, CRG, public.docs repository, COVID sequences, including fast5 files](https://public-docs.crg.es/covid/)
<p align="center">
    <a href="https://public-docs.crg.es/covid/" title="See this resource">
      <img src="https://public-docs.crg.es/icons/logo-crg.png" width="30%"/>
    </a> 
</p>

[COVID-19 ARTIC v3 Illumina library construction and sequencing protocol](https://www.protocols.io/view/covid-19-artic-v3-illumina-library-construction-an-beuzjex6)

[Enrichment workflow for detecting coronavirus using Illumina NGS systems](https://www.illumina.com/content/dam/illumina-marketing/documents/products/appnotes/ngs-enrichment-coronavirus-app-note-1270-2020-002.pdf)

[CDC GitHub SARS-CoV-2 Sequencing Resources](https://github.com/CDCgov/SARS-CoV-2_Sequencing/blob/master/README.md)

[Katarina Braun GitHub ARS-CoV-2_sequencing repository](https://github.com/katarinabraun/SARS-CoV-2_sequencing)

[Broad Institute viral-related pipelines. Several available repositories with scripts and tools for the analysis of viral NGS data](https://github.com/broadinstitute?q=vir&type=&language=)

[CoV Genome Tracker: tracing genomic footprints of Covid-19 pandemic](https://www.biorxiv.org/content/10.1101/2020.04.10.036343v1)
<p align="center">
    <a href="https://www.biorxiv.org/content/10.1101/2020.04.10.036343v1" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/CoV-Genome-Tracker.png" width="30%"/>
    </a> 
</p>

[The global population of SARS-CoV-2 is composed of six major subtypes](https://www.biorxiv.org/content/10.1101/2020.04.14.040782v1)

[A High-Coverage SARS-CoV-2 Genome Sequence Acquired by Target Capture Sequencing](https://www.medrxiv.org/content/10.1101/2020.04.11.20061507v1)


<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>


<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Shiny and R related dashboards and packages"></a>
## Shiny and R related dashboards and packages ##
> Section to show relevant Shiny dashborads, R packages and codes. Under construction...
 
<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>


<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Viral mechanisms and Tropism"></a>
## Viral mechanisms and Tropism: infection, entry, and replication ##
> Section to describe the different mechanisms and tropism that the virus displays. Under construction...

[Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro](https://www.biorxiv.org/content/10.1101/2020.04.07.029884v1)

[Mechanistic modeling of the SARS-CoV-2 disease map](https://www.biorxiv.org/content/10.1101/2020.04.12.025577v1)
<p align="center">
    <a href="http://hipathia.babelomics.org/covid19/" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/CoV-Hipathia.png" width="30%"/>
    </a> 
</p>

[ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy](https://www.medrxiv.org/content/10.1101/2020.03.30.20047878v2)

[ACE2: from vasopeptidase to SARS virus receptor](https://linkinghub.elsevier.com/retrieve/pii/S0165-6147(04)00097-5)

[ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia](http://jvi.asm.org/cgi/pmidlookup?view=long&pmid=16282461)

[ACE2 shedding and furin abundance in target organs may influence the efficiency of SARS-CoV-2 entry](http://www.chinaxiv.org/abs/202002.00082)

[A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV](https://science.sciencemag.org/content/early/2020/04/02/science.abb7269)

[Analysis the susceptibility of lung cancer patients to SARS-CoV-2 infection](https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3558022)

[Angiotensin‐converting enzyme 2 (ACE2) as a SARS‐CoV‐2 receptor: molecular mechanisms and potential therapeutic target](https://link.springer.com/article/10.1007/s00134-020-05985-9)

[Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System](https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.120.317015)

[Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics](https://onlinelibrary.wiley.com/doi/full/10.1002/ddr.21656)

[A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin](https://www.ncbi.nlm.nih.gov/pubmed/32274964)

[A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091172/)

[CD147/EMMPRIN Acts as a Functional Entry Receptor for Measles Virus on Epithelial Cells](https://jvi.asm.org/content/84/9/4183.long)

[Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site](https://www.biorxiv.org/content/10.1101/2020.03.22.002204v1)

[Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV](https://www.nature.com/articles/s41467-020-15562-9)

[Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine](https://www.nature.com/articles/s41423-020-0400-4)

[We shouldn’t worry when a virus mutates during disease outbreaks](https://www.nature.com/articles/s41564-020-0690-4)

[Coronavirus envelope protein: current knowledge](https://virologyj.biomedcentral.com/articles/10.1186/s12985-019-1182-0)

[Coronavirus infections and immune responses](https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25685)

[COVID‐19 in the heart and the lungs: could we “Notch” the inflammatory storm?](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144545/)

[Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation](https://science.sciencemag.org/content/367/6483/1260)

[Cyclophilin–CD147 interactions: a new target for anti-inflammatory therapeutics](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883100/)

[Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility](https://journals.physiology.org/doi/full/10.1152/physrev.00013.2020)

[Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26](https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1739565)

[Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells](https://www.pnas.org/content/117/13/7001)

[Evolutionary stasis of viruses?](https://www.nature.com/articles/s41579-019-0168-7)

[Reply to ‘Evolutionary stasis of viruses?’](https://www.nature.com/articles/s41579-019-0169-6)

[Expression of SARS-CoV-2 receptor ACE2 and the spike protein processing enzymes in developing human embryos](https://arxiv.org/abs/2004.04935)

[Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event](https://www.sciencedirect.com/science/article/pii/S1567134820300447)

[Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses](https://www.nature.com/articles/s41564-020-0688-y)

[Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility](https://www.biorxiv.org/content/10.1101/2020.04.07.024752v1)

[Individual variation of the SARS-CoV2 receptor ACE2 gene expression and regulation](https://www.preprints.org/manuscript/202003.0191/v1)

[Interaction of drugs candidates with various SARS-CoV-2 receptors: an in silico study to combat COVID-19](https://chemrxiv.org/articles/Interaction_of_drugs_candidates_with_various_SARS-CoV-2_receptors_an_in_silico_study_to_combat_COVID-19/12100968/1)

[Is COVID-19 receiving ADE from other coronaviruses?](https://www.sciencedirect.com/science/article/pii/S1286457920300344)

[Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial](https://www.medrxiv.org/content/10.1101/2020.03.21.20040691v1)

[Origin and evolution of pathogenic coronaviruses](https://www.nature.com/articles/s41579-018-0118-9)

[Pandemics: spend on surveillance, not prediction](https://www.nature.com/articles/d41586-018-05373-w)

[Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2](https://www.sciencedirect.com/science/article/pii/S1286457920300496)

[Prisoners of war — host adaptation and its constraints on virus evolution](https://www.nature.com/articles/s41579-018-0120-2)

[Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak](https://linkinghub.elsevier.com/retrieve/pii/S0960-9822(20)30360-2)

[Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347323/)

[Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus](https://jvi.asm.org/content/94/7/e00127-20)

[Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases](https://pubs.acs.org/doi/10.1021/acscentsci.0c00272)

[SARS Coronavirus Redux](https://www.sciencedirect.com/science/article/pii/S1471490620300387)

[SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor](https://www.sciencedirect.com/science/article/pii/S0092867420302294)

[SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion](https://www.nature.com/articles/s41423-020-0424-9)

[SARS-CoV-2 invades host cells via a novel route: CD147-spike protein](https://www.biorxiv.org/content/10.1101/2020.03.14.988345v1)

[SARS-CoV-2 Life Cycle: Stages and Inhibition Targets](https://www.antibodies-online.com/resources/18/5410/sars-cov-2-life-cycle-stages-and-inhibition-targets/)

[SARS-CoV-2 receptor ACE2 and TMPRSS2 are predominantly expressed in a transient secretory cell type in subsegmental bronchial branches](https://www.biorxiv.org/content/10.1101/2020.03.13.991455v3)

[SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells](https://www.ncbi.nlm.nih.gov/pubmed/32246845)

[Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade](https://www.karger.com/Article/FullText/507305)

[Structural basis of receptor cognition by SARS-CoV-2](https://www.nature.com/articles/s41586-020-2179-y)

[Structural interactions between pandemic SARS-CoV-2 spike glycoprotein and human Furin protease](https://www.biorxiv.org/content/10.1101/2020.04.10.036533v1)

[Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein](https://www.sciencedirect.com/science/article/pii/S0092867420302622)

[Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor](https://www.nature.com/articles/s41586-020-2180-5)

[Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-2](https://www.biorxiv.org/content/10.1101/2020.03.30.015347v1)

[Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19](https://www.ijbs.com/v16p1724.htm)

[Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30196-1/fulltext)

[The biology of influenza viruses](https://www.sciencedirect.com/science/article/pii/S0264410X08009377)

[The insert sequence in SARS-CoV-2 enhances spike protein cleavage by TMPRSS](https://www.biorxiv.org/content/10.1101/2020.02.08.926006v3.full)

[The proximal origin of SARS-CoV-2](https://www.nature.com/articles/s41591-020-0820-9)

[The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement]https://www.biorxiv.org/content/10.1101/2020.04.10.036418v1()

[TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein](https://jvi.asm.org/content/88/2/1293.long)

[Tracking virus outbreaks in the twenty-first century](https://www.nature.com/articles/s41564-018-0296-2)

[Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools](https://link.springer.com/article/10.1007%2Fs12250-020-00207-4)

[We shouldn’t worry when a virus mutates during disease outbreaks](https://www.nature.com/articles/s41564-020-0690-4)

[Why do RNA viruses recombine?](https://www.nature.com/articles/nrmicro2614)

[Widely available lysosome targeting agents should be considered as a potential therapy for COVID-19](https://www.preprints.org/manuscript/202003.0345/v2)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>



<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Acknowledgements"></a>
## Acknowledgements ##
> Section to highlight the contributors of many links within this repository.
> Want to share your relevant links? Place a Direct Message to @resocios in Twitter.
<ul>
  <li>Agust&iacute;n Valenzuela Fern&aacute;ndez (ULL) <a href="https://twitter.com/SciArt3D" title="Follow to @SciArt3 on Twitter">@SciArt3</a></li>
  <li>Carlos Javier P&eacute;rez Gonz&aacute;lez (ULL) <a href="https://twitter.com/cpgonzal" title="Follow to @cpgonzal on Twitter">@cpgonzal</a></li>
  <li>Jos&eacute; Luis Roda (ULL) <a href="https://twitter.com/joluroga" title="Follow to @joluroga on Twitter">@joluroga</a></i>
  <li>Marcos Colebrook Santamar&iacute;a (ULL) <a href="https://twitter.com/MColebrook" title="Follow to @MColebrook on Twitter">@MColebrook</a></li>
  <li>Mar&iacute;a López P&eacute;rez (FIMERALL-SEGAI, ULL)</li>
  <li>Carlos Flores Infante (FIISC, ITER) <a href="https://twitter.com/LabCflores" title="Follow to @LabCflores on Twitter">@LabCflores</a></li>
  <li>Contributing PR to this repository, <a href="https://github.com/miguelcorrea" title="Follow to Miguel Correa on GitHub">Miguel Correa (@evocellnet, EMBL-EBI)</a></li>
</ul>

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Contact us"></a>
## Contact us ##
> Want to contact us? We highly encourage people to contribute to this COVID-19 repository (and acknowledged in the section above). Please, send me a Direct Message on Twitter (see below).

 <p align="left">
  <a href="https://www.iter.es/areas/area-genomica/" title="Contact us at the Genomics Division of the Institute of Technology and Renewable Energy (ITER), Tenerife, Canary Islands, Spain">
    <img src="https://www.iter.es/wp-content/uploads/2016/05/logo.png" width="30%" /> 
  </a>
</p>

Last update: 18:25 GMT - April 19, 2020     |     By JMLS <a href="https://twitter.com/resocios" title="Follow to @resocios on Twitter" >@resocios <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/Twitter_Social_Icon_Circle_Color.png" width="32px" /></a>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Update logs"></a>
## Update logs ##

> April 16, 2020 updates: several entries in the Scientific Literature (Preprints & Published); and two new items in data sources.

> April 15, 2020 updates: added Databricks data collection; new CoV Genome Tracker; COVID-19 in Icelandic population; new records in the Education section; new articles about use and disinfection or repirators; more on virus mechanisms; new papers on COVID-19 detection techniques.

> April 14, 2020 updates: more on False Negatives in qPCR, impact of face mask against COVID-19, JAMA review of pharmacological treatments for COVID-19 in the Prepints section; added some Journals Watch pages; dashboard of the Spanish MoMo report about mortality, new dashboard for WHO, and new dashboard with graphical information for COVID-19 data in the Canary Islands by Grafcan-GOBCAN, in the Data Sources section; modeling of the SARS-CoV-2 disease map in the Viral mechanisms section; many new inputs in different sections (>20); new pages "Code of Conduct" and "Contributing to this repository" created.

> April 13, 2020 updates: few new articles in Scientific Literature (Pre-prints & Peer-Reviewed Papers) section and MIDAS COVID-19 repository in Data Sources section. As the repository increases its size, we are moving into a Wiki format (soon here!). Pull request by Miguel Correa added to the main branch of this repository.

> April 12, 2020 updates: new articles regarding COVID-19 detection, a comprehensive draft list of clinical trials by country from WHO (update April 11), dermatological effects of COVID-19, a new report from University of Göttingen, and many more.

> April 11, 2020 updates: new rapid PCR methods to detect COVID-19; warning about the use on non-specific PCR primers and False Negatives; more on the disinfection of respirators.

> April 10, 2020 updates: new logos; new papers in Scientic Literature; new subsection "Maths and Epidemiological Models", where the impact of social distancing and face mask use are presented.

> April 9, 2020 updates: new entries in the scientific literature section (PCR false negatives and COVID-19 affecting newborn babies, among others); new entry in the genomics section; new subsection dedicated to PCR and related topics within the Scientific Literature section; new articles related to respiratory protective equipment and ways to disinfect them; new section about sequencing and sequences.

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>
